Développement d’une nouvelle génération de vaccins thérapeutiques antitumoraux composés de peptides cryptiques optimisés – ESME

(PME (petite et moyenne entreprise))

The author of this summary is the project coordinator, who is responsible for the content of this summary. The ANR declines any responsibility as for its contents.

Help of the ANR 839,937 euros
Beginning and duration of the scientific project: - 36 Months

• List of selected projects
• Permanent link to this summary on the ANR website (ANR-05-PRIB-0027)
• See the publications in the HAL-ANR portal